Epibiotech Co., Ltd. (XKON:446440)
South Korea · Delayed Price · Currency is KRW 19,000
0.00 (0.00%)
At close: Oct 22, 2026
Epibiotech Market Cap
Epibiotech has a market cap or net worth of 46.14 billion as of October 23, 2026. It is the 32,774th most valuable company in the world and the 1,866th biggest in South Korea. Its market cap has increased by 25.16% in one year.
Market Cap
46.14B
Enterprise Value
n/a
Revenue
449.62M
Global Rank
Country Rank
#1,866 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 31, 2023, Epibiotech's market cap has decreased from 58.59B to 46.14B, a decrease of -21.25%. That is a compound annual growth rate of -7.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 43.83B | 26.67% |
| Dec 30, 2025 | 34.60B | -2.83% |
| Dec 30, 2024 | 35.61B | 24.00% |
| Dec 28, 2023 | 28.72B | -50.98% |
| Jul 31, 2023 | 58.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TegoScience | 56.21B |
| ADBiotech | 55.52B |
| KoBioLabs | 52.92B |
| J2KBIO | 49.18B |
| QuadMedicine | 46.73B |
| NovMetaPharma | 46.23B |
| Parataxis Korea | 44.13B |
| HLB Pep | 39.57B |